Loading
AS
Aquarius Surgical Technologies Inc. (formerly Aquarius Coatings Inc.) Stock: price and insider trades · Canada
Insider Decl.
40
Thresholds
n/a
Buy Volume
€42,115
16 ops. · all time
Sell Volume
n/a
n/a
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2026FY ended March 2026 · cache
CA$0.02
Analyst consensus
Income statement
RevenueCA$91.4k
Gross profitCA$49.1k54% margin
EBITDA-CA$234.8k-257% margin
Net income-CA$651.7k-712.7% margin
Valuation
Beta1.48
Balance sheet & cash
Total debtCA$6.9M
Free Cash Flow-CA$116.4k
Profitability & ownership
ROA-5.9%
% insiders51.4%
% institutions0.0%
Last declaration on 31 March 2023
Declarations40 total
4,598,704 shares@ CA$0.0377.6% of flowCommon SharesTSXSEDI:4105927
3,920,000 shares@ CA$0.05Common SharesTSXSEDI:4044051
169,721 sharesCommon SharesTSXSEDI:3921712
169,721 sharesCommon SharesTSXSEDI:3921722
26,251 sharesCommon SharesTSXSEDI:3921729
88,000 sharesCommon SharesTSXSEDI:3919323
154,714 sharesCommon SharesTSXSEDI:3919333
88,000 sharesCommon SharesTSXSEDI:3919316
Common SharesTSXSEDI:3919303
Common SharesTSXSEDI:3916419
100,000 shares@ CA$0.065100.0% of flowCommon SharesTSXSEDI:3916420
Common SharesTSXSEDI:3915776
Common SharesTSXSEDI:3915753
Common SharesTSXSEDI:3915319
Common SharesTSXSEDI:3915311
100,000 shares@ CA$0.065100.0% of flowCommon SharesTSXSEDI:3915779
100,000 shares@ CA$0.065100.0% of flowCommon SharesTSXSEDI:3915313
100,000 shares@ CA$0.065100.0% of flowCommon SharesTSXSEDI:3915321
100,000 shares@ CA$0.065100.0% of flowCommon SharesTSXSEDI:3915302
10,000 shares@ CA$0.328.3% of flowCommon SharesTSXSEDI:3433940
Canonical exit: 5 May 2019 (T+90)
14,500 shares@ CA$0.30Common SharesTSXSEDI:3313136
Canonical exit: 7 May 2019 (T+90)
1,000 shares@ CA$0.30Common SharesTSXSEDI:3310221
Canonical exit: 2 May 2019 (T+90)
21,000 shares@ CA$0.30Common SharesTSXSEDI:3308967
Canonical exit: 1 May 2019 (T+90)
4,500 shares@ CA$0.29Common SharesTSXSEDI:3299709
Canonical exit: 10 Apr 2019 (T+90)
8,000 shares@ CA$0.285.4% of flowCommon SharesTSXSEDI:3297831
Canonical exit: 8 Apr 2019 (T+90)
25 of 40 declarations
About Aquarius Surgical Technologies Inc. (formerly Aquarius Coatings Inc.)
David John Hennigar, a director and senior officer of Aquarius Surgical Technologies Inc. (formerly Aquarius Coatings Inc.), signs 26 of the 39 filings in the record, of which 15 purchases. He also made the largest, EUR 10,007 on September 13, 2018, the day Gary Norman Van Nest, a director, bought EUR 5,003. Between September 13, 2018 and September 20, 2018, 2 filers bought EUR 25,430. David John Hennigar also bought EUR 3,941 on September 19, 2018.
The record's 16 purchases (10 with an amount) total EUR 32,018, with a median of EUR 2,550. No sale is filed; the rest is 5 grants and 18 filings of another kind. Charlotte Marie Janssen, Rajiv Kumar Singal and Stanley Joseph Swierzewski, directors, have no purchase.
Read moreShow less
Filings, published from March 31, 2017 to March 31, 2023, are concentrated in 2022 (17) and 2018 (11), against 2 in 2017, 8 in 2019 and one in 2023. The Toronto company, classified under health care, is valued at CAD 413,988 and insiders hold 51.4% of it. Across 10 purchases with a 90-day return, the stored median is -37.5% (past results on record, not a forecast). No filing falls within the last twelve months.
